BRIEF published on 02/24/2026 at 15:28, 6 months 21 days ago The Vanguard Group Discloses Position in LondonMetric Property Form 8.3 Takeover Code Securities Disclosure Vanguard Group LondonMetric Property
PRESS RELEASE published on 02/24/2026 at 15:28, 6 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.07% interest in JTC plc as of 23-Feb-2026, with 8,748,078 relevant securities owned. Includes purchase of 5,440 1p ordinary securities at 12.99 GBP/unit The Vanguard Group Stock Purchase Securities Ownership Interest Disclosure JTC Plc
BRIEF published on 02/24/2026 at 15:28, 6 months 21 days ago The Vanguard Group Discloses Position in Picton Property Income Limited Form 8.3 Takeover Code Vanguard Group Picton Property Income Property Securities
PRESS RELEASE published on 02/24/2026 at 15:27, 6 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% stake in Beazley plc. Details of the ownership disclosed according to Code Rule 8.3 Vanguard Group Ownership Disclosure Stake Code Rule 8.3 Beazley Plc
BRIEF published on 02/24/2026 at 15:27, 6 months 21 days ago The Vanguard Group Discloses Significant Position in NCC Group plc Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure NCC Group
PRESS RELEASE published on 02/24/2026 at 15:26, 6 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.51% ownership in Schroders plc. Position disclosed on 23 Feb 2026. Details in Form 8.3 The Vanguard Group, Inc. Form 8.3 Schroders Plc Ownership Disclosure Financial Securities
PRESS RELEASE published on 02/24/2026 at 15:26, 6 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses a 0.94% stake in Life Science REIT plc. Details of securities and derivative transactions provided Vanguard Group Stake Disclosure Securities Transactions Derivative Transactions Life Science REIT Plc
PRESS RELEASE published on 02/24/2026 at 15:25, 6 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% interest in Spire Healthcare Group plc. Purchase of 1p ordinary shares at 1.99 GBP per unit on 23 Feb 2026 Disclosure Vanguard Group Spire Healthcare Purchase GBP
PRESS RELEASE published on 02/24/2026 at 15:24, 6 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.92% stake in Just Group plc. Details on ownership, positions, and dealings provided in Form 8.3 submission Form 8.3 Vanguard Group Dealings Ownership Just Group Plc
PRESS RELEASE published on 02/24/2026 at 15:23, 6 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.30% interest in LondonMetric Property plc on 23 Feb 2026. Purchased 186,849 securities at 2.13 GBP per unit Securities The Vanguard Group, Inc. LondonMetric Property Plc Disclosure Purchase
Published on 09/18/2026 at 06:30, 1 hour 48 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 7 hours 23 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 7 hours 53 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 10 hours 3 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 08:05, 13 minutes ago THE TOKYO PASS Renews Official Website, Redefining Wellness Tourism in Tokyo with "Museum Bathing (R)"
Published on 09/18/2026 at 08:00, 18 minutes ago Gledhow Investments plc: Appointment of Aquis Corporate Adviser
Published on 09/17/2026 at 17:40, 14 hours 38 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 14 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 1 hour ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification